Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-25 @ 2:15 AM
NCT ID:
NCT02983760
Eligibility Criteria:
Inclusion Criteria:
* Outpatients with a clinically suspected PE (defined as an acute onset of new or worsening shortness of breath, chest pain, hemoptysis, presyncope, or syncope) without another obvious apparent cause.
* High pretest clinical probability of PE or a non-high pretest clinical probability but a positive D-Dimer test.
Exclusion Criteria:
* Age less than 18 years
* Patients with already confirmed PE
* Patients with a clinically suspected high-risk pulmonary embolism (hypotension or shock)
* Use of therapeutic doses of anticoagulants for more than 48 hours
* Other indication for long-term use of anticoagulants
* Contraindication to contrast media (including renal insufficiency with a creatinine clearance lower than 30 ml/min)
* Life expectancy less than 3 months
* Unable/unwilling to give informed consent
* Unlikely to comply with study follow-up
* Ongoing pregnancy or breastfeeding
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02983760
Study Brief:
Protocol Section:
NCT02983760